A Study to Evaluate the Safety of Epoetin Alfa and Its Effectiveness in Facilitating the Presurgical Collection of Blood From Anemic Patients for Possible Self-transfusion During and After Scheduled Joint Surgery.
Phase 3
Completed
- Conditions
- Anemia
- First Posted Date
- 2005-12-26
- Last Posted Date
- 2011-05-18
- Target Recruit Count
- 77
- Registration Number
- NCT00270062
A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease
Phase 2
Completed
- Conditions
- AnemiaAcquired Immunodeficiency Syndrome
- First Posted Date
- 2005-12-26
- Last Posted Date
- 2011-05-18
- Target Recruit Count
- 72
- Registration Number
- NCT00270010
A Study of the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Undergoing Orthopedic Surgery and Who Have Low Hematocrit Levels (the Percent of Red Blood Cells in Whole Blood)
Phase 2
Completed
- Conditions
- AnemiaBlood TransfusionOrthopedic Procedures
- First Posted Date
- 2005-12-26
- Last Posted Date
- 2011-05-18
- Target Recruit Count
- 55
- Registration Number
- NCT00270114
A Study to Determine the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Not Anemic and Who Will be Undergoing Orthopedic or Heart and Blood Vessel Surgery
Phase 2
Completed
- Conditions
- Blood TransfusionBlood Transfusion, AutologousOrthopedic ProceduresOrthopedic SurgeryCardiovascular Surgical Procedure
- First Posted Date
- 2005-12-26
- Last Posted Date
- 2011-05-18
- Target Recruit Count
- 80
- Registration Number
- NCT00270075
A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy
Phase 2
Completed
- Conditions
- Acquired Immunodeficiency SyndromeAnemia
- First Posted Date
- 2005-12-26
- Last Posted Date
- 2011-05-18
- Target Recruit Count
- 63
- Registration Number
- NCT00270270
A Study to Evaluate the Effectiveness and Safety of Epoetin Alfa During the Period When One is Donating One's Own Blood Before Surgery.
Phase 3
Completed
- Conditions
- Anemia
- First Posted Date
- 2005-12-26
- Last Posted Date
- 2011-05-18
- Target Recruit Count
- 17
- Registration Number
- NCT00270179
A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Patients With Acquired Immunodeficiency Syndrome (AIDS) Who Are Receiving Zidovudine (AZT) Therapy
Phase 2
Completed
- Conditions
- Acquired Immunodeficiency SyndromeAnemia
- First Posted Date
- 2005-12-26
- Last Posted Date
- 2011-05-18
- Target Recruit Count
- 102
- Registration Number
- NCT00270283
A Study to Determine the Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Non-anemic Patients Who Are Undergoing Orthopedic, Heart and Blood Vessel, or Breast Reduction Surgery; Performed in Combination With a Procedure to Reduce Blood Loss During Surgery.
Phase 2
Completed
- Conditions
- Orthopedic ProceduresCardiovascular Surgical ProceduresMammaplastyBlood TransfusionBlood Transfusion, AutologousOrthopedic Surgery
- First Posted Date
- 2005-12-26
- Last Posted Date
- 2011-05-18
- Target Recruit Count
- 112
- Registration Number
- NCT00270023
A Study to Determine the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia Caused by Advanced Cancer
Phase 2
Completed
- Conditions
- Anemia
- First Posted Date
- 2005-12-26
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 56
- Registration Number
- NCT00269984
The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma
Phase 3
Completed
- Conditions
- AnemiaMultiple Myeloma
- First Posted Date
- 2005-12-26
- Last Posted Date
- 2011-05-18
- Target Recruit Count
- 156
- Registration Number
- NCT00270101
© Copyright 2025. All Rights Reserved by MedPath